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1. Introduction 
Exogenous Ca*+ is required for carbamylcholine to 
stimulate glycogenolysis [l] and for noradrenaline to 
stimulate glucose oxidation [2] in rat submaxillary 
gland slices. It is also required for adrenaline to com- 
pletely overcome the inhibition of glucose utilization 
caused by acetoacetate [3]. This latter effect of 
adrenaline is associated with a decrease of tissue 
[ATP] which occurs only when exogenous Ca*+ is 
present [3] . These findings suggest hat Ca2+ might 
be involved in the mechanism by which adrenaline 
exerts some of its metabolic effects. 
Ca*+ may simply be required for the hormone to 
bind to its receptor in the membrane or the hormone- 
receptor interaction may stimulate movement of 
Ca*+ into the cell and thus initiate the metabolic 
response. The ionophore A-23 187 is capable of 
facilitating the movement of Ca*‘and other divalent 
cations across biological membranes [4] and can be 
used as a tool to investigate whether changes in Ca*+ 
flux can alter cellular metabolism. 
Indeed A-23187 stimulates glycogen breakdown 
in submaxillary gland slices [S] and the results 
reported here show that A-23 187 can also stimulate 
glucose uptake and cause the tissue [ATP] to decrease. 
On the other hand, adrenaline was no longer able to 
stimulate glucose metabolism in the presence of 
tetracaine or Ni*‘, which appear’ to inhibit Ca*+ flux 
into cells. 
*Present address: Department of Biochemistry, University 
of Otago, P.O. Box 56, Dunedin, New Zealand. 
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2. Materials and methods 
Male rats of the Wistar strain, weighing 150-200 g 
were used for all experiments. A-23 187 was a gift 
from Eli-Lilly & Co. (Indianapolis, Ind., USA). 
Amethocaine hydrochloride (tetracaine) was obtained 
from Glaxo Laboratories Ltd., Greenford, UK. All 
other enzymes, coenzymes, were obtained as 
previously described [3]. 
A stock solution of A-23187 was prepared in 
methanol at a concentration of 1 mglml. Appropriate 
additions of this solution were made to the incubation 
media to give a final concentration of 10 pg/ml (less 
than 0.1% methanol). Incubations carried out with 
addition of methanol (0.1%) showed no significant 
differences from the control for the parameters 
measured. 
The rats were killed by cervical dislocation and the 
submaxillary glands dissected out into ice-cold saline. 
Slices (0.3-0.4 mm thick) were cut with a razor blade. 
Incubations were carried out in 50 ml Erlenmeyer 
flasks. Each flask contained 200 f 10 mg wet wt. 
slices in Krebs-Henseleit [6] bicarbonate saline 
(5 ml) gassed with 95% 02, 5% CO*, and with glucose 
(5 mM) and appropriate additions, and was incubated 
for 1 h at 37°C in a Dubnoff-type shaker. 
At the end of the incubation period the slices 
were quickly removed from the medium, blotted on 
Whatman No. 1 filter paper, then immediately dropped 
into beakers containing liquid N,. The frozen slices 
were powdered with a cold pestle and mortar, then 
5% HC104 (5 ml) was added and grinding continued 
for 2 min to extract the metabolites. A sample of the 
medium (4 ml) was acidified with 30% HC104 (0.4 ml). 
North-Holland Publishing Company - Amsterdam 
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A control flask containing saline plus additions but 
no tissue was treated in the same manner. The tissue 
extracts and acidified medium were centrifuged for 
10 min at 2000 g in the cold and then the super- 
natants neutralized. Glucose B-phosphate and ATP 
[7] were determined on the tissue extract and 
glucose [8] and lactate [9] were determined on the 
medium. 
3. Results 
The addition of A-23 187 (10 pgjml) to the incuba- 
tion medium caused a 27% stimulation of glucose 
removal by submaxillary gland slices and overcame 
the inhibition of glucose uptake caused by acetoacetate 
(2.5 mM; table 1). This stimulation of glucose removal 
appeared to be due to activation at the phospho- 
fructokinase reaction, as [glucose 6-phosphate] was 
decreased compared with the control (table 1). 
A-23187 caused a 40% decrease in the tissue [ATP] 
(table 1); this decrease could possibly explain the 
observed stimulation of the phosphofructokinase 
reaction (for discussion see [3] ). A greater proportion 
of the glucose removed could be accounted for as 
lactate when A-23 187 was present. None of these 
effects was observed when Ca2+ was omitted from the 
incubation medium (table l), which suggests that 
they result from enhancement of the flux of Ca2+ 
into the cell. 
Stimulation of glucose utilization with an accom- 
panying decrease in the tissue [ATP] also occurs 
when adrenaline is added to the incubation medium 
(table 2 and [3]). So if this indeed was mediated by 
Table 1 
Effects of ionophore A-231 87 on glucose metabolism, [glucose 6-phosphate] and [ ATP) in submaxillary gland slices 
Additions Glucose Lactate Tissue Tissue 
removal formed [glucose 6-phosphate] IA-W 
Glucose 21.4 f 2.4 (8) 8.2 f 0.5 (8) 0.14 * 0.03 (6) 0.83 -I 0.07 (5) 
Glucose + A-2 3 187 27.1 + 3.5 (8)* 14.9 f 2.9 (8)* 0.06 f 0.01 (7)* 0.48 f 0.14 (6)* 
Glucose + A-23187 19.9 + 1.6 (8) 9.9 * 1.1 (9) 0.14 f 0.02 (4) 0.84 f 0.11 (4) 
(Ca’* omitted) 
Glucose + acetoacetate 17.0 f 3.6 (8) 11.9 * 2.1 (4) 0.19 f 0.02 (5)* 0.88 f. 0.14 (6) 
Glucose + 
acetoacetate + 26.2 f 3.9 (6)* 24.0 * 2.1 (4)* 0.05 + 0.01 (6)* 0.40 f 0.09 (6)* 
A-23187 
Metabolite changes are mean values (+ S.D.) expressed as r.rmoles/h/g wet wt. and tissue concentrations are mean values (t SD.) 
expressed as pmoles/g wet wt. Values which are statistically different from the appropriate control by the Student’s t test are 
indicated by * : P < 0.005. 
Table 2 
Effects of tetracaine on glucose metabolism, [glucose 6-phosphate] and [ATP] in submaxillary gland slices 
Additions 
Glucose 
Glucose + tetracaine 




Glucose Lactate Tissue Tissue 
removal formed [glucose 6-phosphate] [ATPI 
20.1 + 3.2 (8) 9.4 f 0.84 (5) 0.14 + 0.02 (8) 0.95 + 0.11 (8) 
24.4 f 1.2 (4) 15.3 f 1.4 (4)* 0.09 f 0.01 (4)* 0.87 f 0.13 (4) 
31.4 f 3.1 (4)* 14.6 f 0.8 (4)* 0.04 ? 0.02 (5)* 0.64 i 0.06 (S)* 
23.5 f 3.2 (4) 18.2 + 2.3 (5)* 0.08 + 0.04 (5)* 0.61 * 0.21 (5)* 
Units as for table 1. Values that are statistically different by the Student’s t test from the glucose control are indicated by * : 
P < 0.005. 
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Table 3 
















19.2 * 5.5 (6) 8.4 f 1.5 (6) 0.12 (2) 0.86 + 0.06 (4) 
18.9 f 4.6 (5) 8.4 f 1.5 (6) 0.19 (2) 0.85 r 0.08 (4) 
31.7 * 2.1 (4)* 13.4 f 2.7 (4)* 0.02 (2) 0.46 + 0.03 (4)* 
16.1 f 3.3 (6) 7.9 f 1.0 (6) 0.16 (2) 0.76 f 0.05 (4) 
Units as for table 1. Values which are statistically different by the Student’s t test from the glucose control are indicated by 
* : P < 0.005. 
an enhanced flux of Ca”into the cell, then the 
effects of adrenaline should be prevented by agents 
which inhibit this process. Tetracaine (1 mM) is a 
compound capable of altering the movement of Ca2’ 
across membranes [lo] and it prevented the stimula- 
tion of glucose removal by adrenaline (10 pg/ml) 
(table 2). The decrease in tissue [glucose &phosphate] 
was also partially prevented by tetracaine (table 2) 
but the lowering of the tissue [ATP] was unaffected. 
An indication that tetracaine may have other meta- 
bolic effects is the greater accumulation of lactate 
in its presence (table 2). 
An ability to interfere with normal calcium flux 
has been attributed to Ni” [ 111. In submaxillary 
gland slices the addition of nickel chloride (0.5 mM) 
prevented the stimulation of glucose uptake and the 
accompanying decreases in tissue [glucose 6-phosphate] 
and [ATP] caused by adrenaline (table 3). 
4. Discussion 
Since A-23 187 is known to facilitate the movement 
of Ca’+across biological membranes [4] it appears from 
the present results that changes in Ca’+movement 
and/or changes in Cap concentration within the sub- 
maxillary gland cells may be sufficient to bring about 
changes in glucose metabolism. It this is true then the 
trigger mechanism for some of the metabolic res- 
ponses to adrenergic stimulation in submaxillary 
gland, especially those requiring exogenous Ca2+, may 
consist of a shift of Ca’+from the cell environment 
(exogenous Ca*‘) and/or from intracellular sites 
(possibly from the mitochondria, secretory granules 
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or other compartments) towards special zones in the 
cytoplasm where the response occurs. The fact that 
both tetracaine and Ni”, which interfere with 
membrane Ca2+ channels, prevent the stimulation of 
glucose utilization by adrenaline supports this sugges- 
tion. 
The metabolic responses to adrenaline that require 
Ca2+ may be the result of stimulation of cu-adrenergic 
receptors since it is known that adrenergic stimulation 
via the a-receptor in a number of other tissues [ 121 
including the parotid gland [ 131 requires exogenous 
Ca”. In contrast, it is generally accepted that changes 
in [cyclic AMP] mediate the responses to /3- 
adrenergic stimulation [ 141 and it is therefore 
significant that exogenous cyclic AMP is unable to 
stimulate glucose utilization or decrease [ATP] in 
the system described here [3]. Phenylephrine, a 
specific o-adrenergic agonist, requires exogenous Ca2+ 
in order to bring about its effects on submaxillary 
gland, whereas isoproterenol, a specific /I-adrenergic 
agonist, does not (M.P. Thompson and D.H Williamson 
unpublished experiments). Similarly, Herman and 
Rossignol [l] have concluded that the /I-adrenergic 
effect of noradrenaline on glycogenolysis in sub- 
maxillary gland is mediated by cyclic AMP, whereas 
the a-adrenergic and cholinergic effects on this process 
are dependent on Ca2+ influx into the cell. 
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